|
|
drug metabolic process
|
GO:0017144 |
4 |
0.840
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.793
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.644
|
|
|
|
benzene containing compound metabolic process
|
GO:0042537 |
5 |
0.637
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.568
|
Human |
|
|
short chain fatty acid catabolic process
|
GO:0019626 |
2 |
0.440
|
|
|
|
naphthalene containing compound metabolic process
|
GO:0090420 |
1 |
0.360
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.332
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.304
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.290
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.256
|
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.255
|
Mouse |
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.250
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.238
|
|
|
|
regulation of estrogen secretion
|
GO:2000861 |
1 |
0.234
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.229
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.200
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.193
|
|
|
|
sulfate assimilation
|
GO:0000103 |
3 |
0.193
|
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.191
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.183
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.181
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.181
|
|
|
|
naphthalene metabolic process
|
GO:0018931 |
1 |
0.179
|
|
|
|
response to nitrosative stress
|
GO:0051409 |
1 |
0.165
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.159
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.148
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.144
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.136
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.131
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.120
|
|
|
|
toxin catabolic process
|
GO:0009407 |
1 |
0.116
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.110
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.110
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.106
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.104
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.104
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.103
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.096
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.096
|
|
|
|
nadph regeneration
|
GO:0006740 |
2 |
0.094
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.091
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.086
|
|
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.084
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.081
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.081
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.081
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.079
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.079
|
|
|
|
acetate metabolic process
|
GO:0006083 |
1 |
0.077
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.077
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.076
|
|
|
|
renal tubular secretion
|
GO:0097254 |
2 |
0.075
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.074
|
|
|
|
acetylcholine catabolic process
|
GO:0006581 |
1 |
0.074
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.072
|
|
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.072
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.071
|
|
|
|
ethanol metabolic process
|
GO:0006067 |
3 |
0.070
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.070
|
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.070
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.069
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.067
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.067
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.067
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.066
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.065
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.065
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.065
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.064
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.063
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.063
|
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.061
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.061
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.060
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.060
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.060
|
Human |
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.060
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.059
|
|
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.058
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.058
|
|
|
|
negative regulation of complement activation
|
GO:0045916 |
3 |
0.057
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.057
|
|
|
|
nadp metabolic process
|
GO:0006739 |
6 |
0.056
|
Human |
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.055
|
|
|
|
negative regulation of protein activation cascade
|
GO:2000258 |
3 |
0.054
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.054
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.053
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.051
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.050
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.050
|
|
|
|
oxidoreduction coenzyme metabolic process
|
GO:0006733 |
16 |
0.050
|
Human |
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.049
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.049
|
Human |
|
|
glycerolipid catabolic process
|
GO:0046503 |
16 |
0.048
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.048
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.047
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.047
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.047
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.046
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.045
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.044
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.044
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.043
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.043
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.043
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.042
|
Rat |
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.042
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.042
|
|
|
|
xenobiotic catabolic process
|
GO:0042178 |
1 |
0.042
|
|
|
|
porphyrin containing compound metabolic process
|
GO:0006778 |
22 |
0.041
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.041
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.040
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.040
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.039
|
|
|
|
response to xenobiotic stimulus
|
GO:0009410 |
13 |
0.039
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.039
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.039
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.039
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.039
|
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.038
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.038
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.038
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.037
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.037
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.037
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.037
|
Human |
|
|
activation of immune response
|
GO:0002253 |
138 |
0.037
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.036
|
|
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
15 |
0.036
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.036
|
|
|
|
organic hydroxy compound catabolic process
|
GO:1901616 |
25 |
0.036
|
|
|
|
regulation of blood vessel size by renin angiotensin
|
GO:0002034 |
5 |
0.036
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.036
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.035
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.035
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.035
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.035
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.035
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.034
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.033
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.033
|
|
|
|
heme metabolic process
|
GO:0042168 |
16 |
0.032
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.032
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.031
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.031
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.031
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.031
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.031
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.031
|
|
|
|
short chain fatty acid metabolic process
|
GO:0046459 |
6 |
0.031
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.031
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.030
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.030
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.030
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.030
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.030
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.030
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.030
|
|
|
|
primary alcohol metabolic process
|
GO:0034308 |
11 |
0.030
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.030
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.029
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.029
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.029
|
|
|
|
pyridine containing compound metabolic process
|
GO:0072524 |
14 |
0.029
|
Human |
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.029
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.029
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.028
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.028
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.028
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.028
|
Human |
|
|
polyamine catabolic process
|
GO:0006598 |
2 |
0.028
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.028
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.028
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.028
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.028
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.027
|
|
|
|
long chain fatty acid import
|
GO:0044539 |
2 |
0.027
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.027
|
|
|
|
retinoic acid metabolic process
|
GO:0042573 |
12 |
0.027
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.027
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.026
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.026
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.026
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.026
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.026
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.026
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.026
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.025
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.025
|
|
|
|
estrogen secretion
|
GO:0035937 |
1 |
0.025
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.025
|
|
|
|
neurotransmitter catabolic process
|
GO:0042135 |
3 |
0.025
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.025
|
|
|
|
positive regulation of estrogen secretion
|
GO:2000863 |
1 |
0.025
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.025
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.025
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.025
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.025
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.024
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.024
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.024
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.024
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.024
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.024
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.024
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.024
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.024
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.023
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.023
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.023
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.023
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.023
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.023
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.023
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.023
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.022
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.022
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.022
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.022
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.022
|
Rat |
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.022
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.022
|
|
|
|
very low density lipoprotein particle assembly
|
GO:0034379 |
2 |
0.022
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.022
|
|
|
|
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure
|
GO:0003072 |
5 |
0.022
|
|
|
|
female genitalia morphogenesis
|
GO:0048807 |
3 |
0.022
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.022
|
|
|
|
glutathione metabolic process
|
GO:0006749 |
16 |
0.022
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.022
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.022
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.022
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.022
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.021
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.021
|
|
|
|
apical junction assembly
|
GO:0043297 |
15 |
0.021
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.021
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.021
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.021
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.021
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.021
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.021
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.021
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.021
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.021
|
|
|
|
cardiac muscle cell proliferation
|
GO:0060038 |
31 |
0.021
|
|
|
|
retinol metabolic process
|
GO:0042572 |
9 |
0.021
|
|
|
|
female meiosis chromosome segregation
|
GO:0016321 |
1 |
0.020
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.020
|
|
|
|
receptor biosynthetic process
|
GO:0032800 |
3 |
0.020
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.020
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.020
|
|
|
|
acylglycerol biosynthetic process
|
GO:0046463 |
18 |
0.020
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.020
|
|
|
|
alcohol catabolic process
|
GO:0046164 |
16 |
0.020
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.020
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.019
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.019
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.019
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.019
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.019
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.019
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.019
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.019
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.019
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.019
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.019
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.019
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.019
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.019
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.019
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.019
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.019
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.018
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.018
|
|
|
|
nitrobenzene metabolic process
|
GO:0018916 |
1 |
0.018
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.018
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.018
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.018
|
|
|
|
regulation of tooth mineralization
|
GO:0070170 |
2 |
0.018
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.018
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.018
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.018
|
|
|
|
fatty acid transmembrane transport
|
GO:1902001 |
1 |
0.018
|
|
|
|
hematopoietic stem cell migration
|
GO:0035701 |
1 |
0.018
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.018
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.018
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.018
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.018
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.018
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.018
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.018
|
|
|
|
linoleic acid metabolic process
|
GO:0043651 |
6 |
0.018
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.018
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.018
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.018
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.018
|
|
|
|
exogenous drug catabolic process
|
GO:0042738 |
1 |
0.018
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.017
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.017
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.017
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.017
|
|
|
|
fat soluble vitamin metabolic process
|
GO:0006775 |
11 |
0.017
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.017
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.017
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.017
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.017
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.017
|
|
|
|
aldehyde catabolic process
|
GO:0046185 |
4 |
0.017
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.017
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.017
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.017
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.017
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.017
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.017
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.016
|
|
|
|
formaldehyde metabolic process
|
GO:0046292 |
1 |
0.016
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.016
|
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.016
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.016
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.016
|
|
|
|
endocrine hormone secretion
|
GO:0060986 |
15 |
0.016
|
|
|
|
long chain fatty acid metabolic process
|
GO:0001676 |
26 |
0.016
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.016
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.016
|
|
|
|
acylglycerol catabolic process
|
GO:0046464 |
11 |
0.016
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.016
|
|
|
|
oxygen metabolic process
|
GO:0072592 |
4 |
0.016
|
Mouse |
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.016
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.016
|
|
|
|
regulation of complement activation
|
GO:0030449 |
7 |
0.015
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.015
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.015
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.015
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.015
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.015
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.015
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.015
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.015
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.015
|
|
|
|
plasma membrane long chain fatty acid transport
|
GO:0015911 |
1 |
0.015
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.015
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.015
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.015
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.015
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.015
|
|
|
|
negative regulation of reproductive process
|
GO:2000242 |
31 |
0.015
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.015
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.015
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.015
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.015
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.015
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.015
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.015
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.015
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.014
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.014
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.014
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.014
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
36 |
0.014
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.014
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.014
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.014
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.014
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.014
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.014
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.014
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.014
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.014
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.014
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.014
|
|
|
|
regulation of chloride transport
|
GO:2001225 |
2 |
0.014
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.014
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.014
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.014
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.014
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.014
|
|
|
|
primary alcohol catabolic process
|
GO:0034310 |
2 |
0.014
|
|
|
|
nicotinamide nucleotide metabolic process
|
GO:0046496 |
12 |
0.014
|
Human |
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.014
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.014
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.014
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.014
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.014
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.014
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.013
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.013
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.013
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.013
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.013
|
|
|
|
regulation of triglyceride biosynthetic process
|
GO:0010866 |
10 |
0.013
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.013
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.013
|
|
|
|
positive regulation of steroid hormone secretion
|
GO:2000833 |
2 |
0.013
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.013
|
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.013
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.013
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.013
|
|
|
|
positive regulation of lipid transport
|
GO:0032370 |
22 |
0.013
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.013
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.013
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.013
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.013
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.013
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.013
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.013
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.013
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.013
|
|
|
|
fatty acid catabolic process
|
GO:0009062 |
25 |
0.013
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.013
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.013
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.013
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.013
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.013
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.013
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.013
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.013
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.013
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.013
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.013
|
|
|
|
polyol metabolic process
|
GO:0019751 |
26 |
0.012
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.012
|
|
|
|
positive regulation of monocyte chemotaxis
|
GO:0090026 |
2 |
0.012
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.012
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.012
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.012
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.012
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.012
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.012
|
|
|
|
neutral lipid biosynthetic process
|
GO:0046460 |
18 |
0.012
|
|
|
|
mesenchymal cell proliferation
|
GO:0010463 |
44 |
0.012
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.012
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.012
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.012
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.012
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.012
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.012
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.012
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.012
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.012
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.012
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.012
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.012
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.012
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.012
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.012
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.012
|
|
|
|
cellular biogenic amine catabolic process
|
GO:0042402 |
5 |
0.012
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.012
|
|
|
|
sodium ion export from cell
|
GO:0036376 |
1 |
0.012
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.012
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.012
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.012
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.012
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.012
|
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.012
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.012
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.012
|
|
|
|
sphingolipid catabolic process
|
GO:0030149 |
7 |
0.012
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.012
|
|
|
|
renal system process involved in regulation of blood volume
|
GO:0001977 |
4 |
0.012
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.012
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.012
|
|
|
|
complement activation
|
GO:0006956 |
16 |
0.012
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.012
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.012
|
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.012
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.012
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.012
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.012
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.011
|
|
|
|
physiological muscle hypertrophy
|
GO:0003298 |
3 |
0.011
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.011
|
|
|
|
energy reserve metabolic process
|
GO:0006112 |
39 |
0.011
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.011
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.011
|
|